Backed by brilliant minds, our considerable knowledge guides drug developers through their journey. Explore our comprehensive scientific resources, including whitepapers, technical slide decks, webinars, and more. Our valuable insights and groundbreaking data can help you overcome the unique challenges of advanced therapeutic development.
Insights
4 September 2026
|7 min read
RoukenBio’s human donor-derived air-liquid interface (ALI) asthma model recreates key features of Type 2 airway inflammation, including mucus production and epithelial remodelling. Discover how this translational platform supports target validation, biomarker analysis and therapeutic evaluation in asthma drug discovery.
Insights
5 August 2026
|5 min read
Explore how RoukenBio’s patient-derived ex vivo IBD model preserves key tissue compartments to support more clinically relevant therapeutic testing for Crohn’s disease and ulcerative colitis.
Insights
22 July 2026
|5 min read
Immune checkpoint blockade has transformed immuno-oncology by turning T cell biology into a powerful therapeutic strategy. This article explores how checkpoint science continues to evolve, from PD-1/PD-L1 therapies to next-generation targets, and why revisiting landmark studies like Barber et al. (2006) remains valuable for linking immune mechanisms to functional outcomes.
Insights
10 July 2026
|5 min read
Discover how precision B cell depletion strategies are advancing immuno-oncology, and how RoukenBio’s translational assay platforms support smarter therapeutic development.
🗓️ Stay informed with our monthly scientific newsletter, published on LinkedIn on the last Wednesday of each month.
These editions bring you the latest in drug development breakthroughs, industry trends, and expert insights from the brilliant minds at RoukenBio.
Subscribe today on LinkedInDifficulty doesn’t deter us; it inspires us. Give us a problem, and we’ll find your solution. Our versatile specialists embrace every obstacle as an opportunity to showcase our innovative thinking and problem-solving prowess.
